Chemotherapy resistance and stemness in mitotically quiescent human breast cancer cells identified by fluorescent dye retention

20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years

(2017) Hongchao Pan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Anti-angiogenic drugs: direct anti-cancer agents with mitochondrial mechanisms of action

(2017) Lewis A. Quayle et al.   Oncotarget

Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis

(2017) Wenzhe Li et al.   Scientific Reports

New Insights into the Crossroads between EMT and Stemness in the Context of Cancer

(2016) Isabel Fabregat et al.   Journal of Clinical Medicine

CD24 Is Not Required for Tumor Initiation and Growth in Murine Breast and Prostate Cancer Models

(2016) Natascha Cremers et al.   PLoS One

Mitotic quiescence, but not unique “stemness,” marks the phenotype of bone metastasis-initiating cells in prostate cancer

(2015) Ning Wang et al.   FASEB JOURNAL

A novel method for monitoring tumor proliferation in vivo using fluorescent dye DiD

(2014) Kenji Yumoto et al.   CYTOMETRY PART A

Breast Cancer Stem Cells Transition between Epithelial and Mesenchymal States Reflective of their Normal Counterparts

(2014) Suling Liu et al.   Stem Cell Reports

From seeing to believing: labelling strategies for in vivo cell-tracking experiments

(2013) F. Progatzky et al.   Interface Focus

PKH26 Can Transfer to Host Cells In Vitro and Vivo

(2012) Peng Li et al.   STEM CELLS AND DEVELOPMENT

Evidence for label-retaining tumour-initiating cells in human glioblastoma

(2011) Loic P. Deleyrolle et al.   BRAIN

Resistance to apoptosis-inducing stimuli in CD44+ head and neck squamous cell carcinoma cells

(2011) Kazuaki Chikamatsu et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Slow-Cycling Therapy-Resistant Cancer Cells

(2011) Nathan Moore et al.   STEM CELLS AND DEVELOPMENT

Normal and malignant epithelial cells with stem-like properties have an extended G2 cell cycle phase that is associated with apoptotic resistance

(2010) Lisa J Harper et al.   BMC CANCER

CD44posCD49fhiCD133/2hi Defines Xenograft-Initiating Cells in Estrogen Receptor–Negative Breast Cancer

(2010) Matthew J. Meyer et al.   CANCER RESEARCH

A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth

(2010) Alexander Roesch et al.   CELL

Establishment and characterization of multi-drug resistant, prostate carcinoma-initiating stem-like cells from human prostate cancer cell lines 22RV1

(2010) Te Liu et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells

(2010) M-Q Gao et al.   ONCOGENE

Regeneration of intestinal stem/progenitor cells following doxorubicin treatment of mice

(2009) Christopher M. Dekaney et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Cancer Stem Cells and Aneuploid Populations within Developing Tumors Are the Major Determinants of Tumor Dormancy

(2009) A. P. Kusumbe et al.   CANCER RESEARCH

Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature

(2009) Emmanuelle Charafe-Jauffret et al.   CANCER RESEARCH

Characterization and functional analysis of a slow cycling stem cell-like subpopulation in pancreas adenocarcinoma

(2009) Jennifer L. Dembinski et al.   CLINICAL & EXPERIMENTAL METASTASIS

Survival of the Fittest: Cancer Stem Cells in Therapeutic Resistance and Angiogenesis

(2008) Christine E. Eyler et al.   JOURNAL OF CLINICAL ONCOLOGY